AUS-131

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameAUS-131
Drug Alias Name(S)-Equol(S)EquolAUS-131
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptor beta agonists
TargetsEstrogen receptor beta
Therapy Area/IndicationsMenopausal symptomsCognitive DysfunctionCognition Disorders +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaIndia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAusio Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Colorado DenverNational Institute On Aging (NIA)
Inactive CompaniesUT Health San AntonioNexgen Dermatologics IncAusio Pharmaceuticals Llc
Active IndicationsCognitive DysfunctionCognition DisordersArteriosclerosis +[6] 
Inactive IndicationsMenopausal symptomsAcne VulgarisProstatic Hyperplasia +[5] 

Other Information

ATC CodeN/A
Related LinksWikipedia